Michael Hennig

发表

Tyramine fragment binding to BACE-1.

Martin Stahl, Walter Huber, Thilo Enderle, 2008, Bioorganic & medicinal chemistry letters.

The catalytic mechanism of indole-3-glycerol phosphate synthase: crystal structures of complexes of the enzyme from Sulfolobus solfataricus with substrate analogue, substrate, and product.

M. Hennig, K. Kirschner, J. Jansonius, 2002, Journal of molecular biology.

Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV.

Walter Huber, Armin Ruf, Bernd Löffler, 2003, Structure.

Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors.

Daniel Hunziker, Holger Fischer, Bernd Kuhn, 2010, Bioorganic & medicinal chemistry letters.

Aminomethylpyrimidines as novel DPP-IV inhibitors: a 10(5)-fold activity increase by optimization of aromatic substituents.

Silja Weber, Jens-Uwe Peters, Bernd Kuhn, 2004, Bioorganic & medicinal chemistry letters.

Crystallization Scale Preparation of a Stable GPCR Signaling Complex between Constitutively Active Rhodopsin and G-Protein

Gebhard F. X. Schertler, Dawei Sun, Dmitry B. Veprintsev, 2014, PloS one.

The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment.

Jörg Benz, D. Banner, A. Rufer, 2006, Structure.

Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose

Armin Ruf, Jörg Benz, A. Rufer, 2011, Proceedings of the National Academy of Sciences.

Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 A resolution.

Francis Müller, Edilio Borroni, Daniel Schlatter, 2005, Acta crystallographica. Section D, Biological crystallography.

Discovery of carmegliptin: a potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Holger Fischer, Bernd Kuhn, B. Kuhn, 2010, Bioorganic & medicinal chemistry letters.

1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors.

Jens-Uwe Peters, Bernd Löffler, Daniel Hunziker, 2007, Bioorganic & medicinal chemistry letters.

Molecular recognition of ligands in dipeptidyl peptidase IV.

Bernd Kuhn, B. Kuhn, P. Mattei, 2007, Current topics in medicinal chemistry.

SYNTHESIS AND STRUCTURE ELUCIDATION OF A NEW POTENT SANDALWOOD-OIL SUBSTITUTE

M. Hennig, G. Fráter, Jerzy A. Bajgrowicz, 1998 .

Structure of the human fatty acid synthase KS-MAT didomain as a framework for inhibitor design.

Armin Ruf, Jörg Benz, M. Rudolph, 2010, Journal of molecular biology.

Ligand channel in pharmacologically stabilized rhodopsin

Gebhard F. X. Schertler, Markus G. Rudolph, Andre Alker, 2018, Proceedings of the National Academy of Sciences.